Our read is that lowering the risk of cognitive decline is Well Supported through preventative neurology and mindful lifestyle choices.
Our read is that the medical field is increasingly focused on preventative neurology and promoting health in healthy brains, as cognitive function generally shows a linear decrease with increasing age.
Experts suggest that maintaining neuronal function, managing inflammatory responses, and engaging in activities that recruit neuromodulators can support cognitive health.
Conversely, factors such as excessive screen time, nicotine use, and certain injuries or substance use are seen as detrimental to brain health and development.
To lower the risk of cognitive decline, consider engaging in ambulation to recruit neuromodulators like epinephrine and dopamine, which may increase alertness and cognitive improvements, as noted by Andrew Huberman. Developing a theory of mind that understands other players' mindsets is also crucial for development, according to Andrew Huberman. For individuals with ADHD, Peter Attia suggests that switching between different formulations of methylphenidate can lead to improved outcomes if the initial formulation was not effective, and Andrew Huberman adds that ADHD stimulant medications can provide excellent relief when prescribed appropriately.
Our experts caution against several factors that may increase the risk of cognitive decline. Nicotine use is detrimental to adolescent brain development and can lead to brain rewiring (Andrew Huberman, Paul Saladino, 4x). Excessive smartphone use in early childhood can lead to increased rates of suicide, depression, anxiety, and diminished learning and adaptive behaviors (Andrew Huberman, 2x), with Paul Saladino adding that giving children iPads as a digital babysitter may hinder healthy development. Bryan Johnson also notes that excessive exposure to smartphone addiction, internet gaming, and binge-watching can lead to scatteredness, anxiety, reactivity, and physiological changes in the brain. Sustaining severe injuries like orbital fractures in professional fighting may lead to quitting due to brain damage concerns (Peter Attia, 1x), and clinicians unaware of recent advances in concussion treatment can lead to mismanagement (Peter Attia, 2x). Peter Attia also warns that regular use of ketamine can lead to severe bladder problems and a psychiatric state mimicking schizophrenia, while Andrew Huberman advises caution regarding stem cell therapy abroad for stroke or head injury due to unknown cell sources and potential complications. Resistance training workouts longer than 75 minutes can lead to fatigue that impairs cognitive function (Andrew Huberman, 1x), and missed sleep leads to lost memory consolidation opportunities (Andrew Huberman, 1x). Paul Saladino highlights that post-finasteride syndrome can cause a wide range of severe symptoms including memory problems and slow thinking. Bryan Johnson also points out that PFAS can lead to neurodevelopmental issues.
The verdict would change if new evidence emerged demonstrating that preventative neurology is ineffective, or if large-scale studies showed that cognitive function does not linearly decrease with age. Additionally, if the long-term effects of chronic, non-clinical use of stimulants were better understood and found to be beneficial, or if ketogenic diets were definitively proven effective for all patients with cognitive issues, this could alter our understanding.
The intervention improves the primary outcome at standard doses in healthy adults.
Mechanistic and trial evidence converge on a real, replicable effect.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
The intervention improves the primary outcome at standard doses in healthy adults.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.
Animal-model results don't translate to the human protocol being recommended.